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By deploying myelofibrosis as the disease context, I 
wish to propose that increased availability of Tmp21 
(an NFAT gene target1) induces aberrant protein 
secretion from the ER contributing to pathological 
consequences, which has not been elucidated before. 
Primary myelofibrosis is now mainly considered as an 
advanced stage of BCR-ABL1 negative 
myeloproliferative neoplasms (MPN), which otherwise  
include polycythemia vera and essential 
thrombocythemia. Myelofibrosis is defined by an 
increased insoluble collagen fiber deposition  in the 
bone marrow2 and harbors chronic inflammation as an 
important component in disease progression2.  
 
It has been demonstrated that the event 
responsible for MPN is the uncontrolled 
proliferation of myeloid precursors in the bone 
marrow due to somatic mutations that 
constitutively activate the JAK-STAT pathway 
through cytokine receptors leading to cell 
transformation3-8. In primary myelofibrosis, 
these mutations are associated with other 
mutations in several pathways, which may 
induce differentiation defects (myelodysplastic 
features). The key cell type in the development 
of this fibrosis  appears to be megakaryocytes 
which secrete numerous pro-inflammatory 
protein molecules in an uncontrolled manner, 
causing aberrant re-programming of bone 
marrow mesenchymal stromal cells (BM-
MSCs), extracellular matrix proteins secretion 
and inhibition of normal hematopoiesis 2.  
In myelofibrosis associated megakaryocytes, 
upregulation of NFAT gene expression via 
Flt3 hyperactivation has been reported in the 
context of inflammation2 and Tmp21 is one of 
the NFAT targets expressed in majority of the 
human tissues9, which may be involved in this 
abnormal protein secretion. 
First, Tmp21 is an ER-Golgi associated protein 
cargo receptor which gets substantially 
activated to secrete proteins only upon ER 
stress to inhibit development of acute ER 
stress by establishing adaptive ER 
homeostasis. Further, ER resident misfolded 
GPI anchored proteins access extracellular 
space transiently through ER stress induced 
activation of Tmp21 mediated secretory 
pathway. Moreover, during ER stress 
conditions Tmp21 dominates over Calnexin 
function (soluble/mature protein fold inducing 
ER chaperone) and secretes 
insoluble/misfolded proteins to extracellular 
space10 and in addition, increased availability 
of Tmp21 induces secretion of immature 
amyloid precursor protein (APP) by inhibiting 
maturation of nascent APP polypeptide 
chain11, which altogether would hint that  
 
increased activation of Tmp21 mediated  
secretory pathway could have detrimental 
effects on the secretory proteins concerning 
their normal protein quality assessment and 
regulated secretion. Second, inhibition of 
Tmp21 causes apoptosis of transformed 
cells12,13, which indicates that Tmp21 mediated 
protein secretory pathway plays an active role 
in survival and proliferation of transformed 
cells.  
Based on the so far mentioned experimentally 
proven facts, I wish to put forward the model 
for the responsible mechanism by explaining it 
in myelofibrosis associated megakaryocytes as 
constitutive activation of STAT-5 and STAT-3 
transcriptional factors cause over-expression of 
secretory proteins including pro-inflammatory 
molecules14 resulting in ER protein folding 
overburden that may naturally lead to ER 
stress. Thus, ER stress activates Tmp21 
mediated secretory pathway which may cause 
aberrant secretion of immature/insoluble pro-
inflammatory molecules to the extracellular 
space leading to aberrant and transient 
activation of pro-inflammatory pathways 
causing initiation of chronic inflammation and 
pathological re-programming of BM-MSCs. 
Therefore, detailed investigation of the effects 
of Tmp21 inhibition as a novel targeted drug 
therapy may provide immediate clinical 
benefits in the treatment of myelofibrosis 
associated chronic inflammation. Moreover, as 
ER stress induced chronic inflammation 
persists in several different pathological 
conditions and are difficult to treat with the 
currently available treatment regimens15, 
hence, Tmp21 inhibitors may serve as targeted 
drug therapy to treat such diseases. Ultimately, 
Tmp21 inhibitors development may replace 
the therapeutic strategy of directly targeting 
ER stress activated unfolded protein response 
(UPR) pathway to avoid adverse side effects of 
UPR inhibitors. 
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